Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | HPGD | P15428 | 6/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | STAT1 | P42224 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | CLK1 | P49759 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6408473 | 0.88 | SMN1; SMN2 (0.55) | RAB9ANPC1SMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL6403885 | 0.78 | SMN1; SMN2 (0.45) | RAB9ANPC1SMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL6405499 | 0.75 | ALDH1A1 (0.46) | RAB9ANPC1SMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL6406930 | 0.75 | ALDH1A1 (0.53) | RAB9ANPC1SMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL16907285 | 0.72 | BTK (0.49) | RAB9ANPC1SMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL9693032 | 0.71 | HPGD (0.57) | RAB9ANPC1SMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL30630392 | 0.70 | ESR2 (0.55) | ALDH1A1HPGDMEN1KMT2AKDM4E | |
| SCHEMBL14856915 | 0.70 | ESR2 (0.55) | ALDH1A1HPGDMEN1KMT2AKDM4E | |
| SCHEMBL31264147 | 0.70 | ESR2 (0.55) | ALDH1A1HPGDMEN1KMT2AKDM4E | |
| SCHEMBL6406665 | 0.70 | NPY5R (0.42) | RAB9ANPC1SMN1; SMN2ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050288347-A1 | Certain triazole-based compounds, compositions, and uses thereof | AGRIUS GROUP, LLC. | 2005-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288347-A1 | Certain triazole-based compounds, compositions, and uses thereof | ABCG2, ATP5ME, DNTT | RAB9A 4278/4885NPC1 2070/4885SMN1; SMN2 4793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.